Sign inJoin waitlistJoin the waitlist

Rishi Singh

Chair, Department of Ophthalmology · Mass General Brigham

Credentials: · · · · · ·

History

Department of Ophthalmology · Mass General Brigham
Present

Cleveland Clinic
2006–2007
Ophthalmology
Massachusetts Eye and Ear Infirmary
2002–2005
Tufts Medical Center
2001–2002
Boston University School of Medicine
1997–2001

Research

Bariatric Surgery versus Intensive Medical Therapy for Diabetes - 5-Year Outcomes
New England Journal of Medicine · 2017 · 2,091 citations
Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study
Ophthalmology · 2010 · 686 citations
Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled,…
The Lancet · 2023 · 430 citations

Katherine Talcott
118 papers · 1 as a fellow
Peter Kaiser
61 papers
Justis Ehlers
56 papers
Aleksandra Rachitskaya
45 papers
Sunil Srivastava
45 papers
JM
Justin Muste
36 papers · 31 as a resident
David Kaelber
33 papers
Andrew Schachat
31 papers
TG
Tyler Greenlee
27 papers · 17 as a resident
Grant Hom
26 papers · 1 as a resident
Matthew Russell
26 papers · 13 as a resident
Alex Yuan
25 papers · 3 as a fellow

Clinical trials

Treatment of Diabetic Macular Edema With Aflibercept in Subjects Previously Treated With Ranibizumab or Bevacizumab
Principal investigator · Completed · Phase 4
Rishi Singh
2015–2020
Prevention of Macular Edema In Patients With Diabetic Retinopathy Undergoing Cataract Surgery
Principal investigator · Completed · Phase 1, Phase 2
Rishi Singh
2013–2020
Wet Macular Degeneration Study to Compare Ranibizumab or Bevacizumab to Aflibercept
Principal investigator · Completed · Phase 4
Rishi Singh
2012–2015